Načítá se...
A placebo-controlled crossover study of iloperidone augmentation for residual anger and irritability in major depressive disorder
BACKGROUND: Even when patients experience remission with antidepressants, many continue to report anger attacks and excessive irritability despite continued treatment. Iloperidone antagonizes 5-HT-2a, D2, and alpha-1 receptors, which can have anti-aggressive effects. We examined iloperidone’s safety...
Uloženo v:
| Vydáno v: | Ther Adv Psychopharmacol |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
SAGE Publications
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4749740/ https://ncbi.nlm.nih.gov/pubmed/26913173 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2045125315618621 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|